IN2013MU02055A - - Google Patents
Info
- Publication number
- IN2013MU02055A IN2013MU02055A IN2055MU2013A IN2013MU02055A IN 2013MU02055 A IN2013MU02055 A IN 2013MU02055A IN 2055MU2013 A IN2055MU2013 A IN 2055MU2013A IN 2013MU02055 A IN2013MU02055 A IN 2013MU02055A
- Authority
- IN
- India
- Prior art keywords
- amorphous linagliptin
- preparation
- provides
- improved process
- linagliptin
- Prior art date
Links
- LTXREWYXXSTFRX-QGZVFWFLSA-N Linagliptin Chemical compound N=1C=2N(C)C(=O)N(CC=3N=C4C=CC=CC4=C(C)N=3)C(=O)C=2N(CC#CC)C=1N1CCC[C@@H](N)C1 LTXREWYXXSTFRX-QGZVFWFLSA-N 0.000 abstract 4
- 229960002397 linagliptin Drugs 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract 1
- 208000001280 Prediabetic State Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 201000009104 prediabetes syndrome Diseases 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2055MU2013 IN2013MU02055A (enExample) | 2013-06-18 | 2013-06-18 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2055MU2013 IN2013MU02055A (enExample) | 2013-06-18 | 2013-06-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU02055A true IN2013MU02055A (enExample) | 2015-07-03 |
Family
ID=54396351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2055MU2013 IN2013MU02055A (enExample) | 2013-06-18 | 2013-06-18 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU02055A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019064214A1 (en) * | 2017-09-27 | 2019-04-04 | Biocon Limited | INTERMEDIATE OF CRYSTALLINE LINAGLIPTIN AND PROCESS FOR THE PREPARATION OF LINAGLIPTIN |
-
2013
- 2013-06-18 IN IN2055MU2013 patent/IN2013MU02055A/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019064214A1 (en) * | 2017-09-27 | 2019-04-04 | Biocon Limited | INTERMEDIATE OF CRYSTALLINE LINAGLIPTIN AND PROCESS FOR THE PREPARATION OF LINAGLIPTIN |
| US11040974B2 (en) | 2017-09-27 | 2021-06-22 | Biocon Limited | Crystalline linagliptin intermediate and process for preparation of linagliptin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| PH12015501648A1 (en) | 2-aminopyrimidine derivatives for the treatment of viral infections | |
| HK1255162A1 (zh) | 爱帕琳肽受体激动剂及使用方法 | |
| MY169159A (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
| MX2021011906A (es) | Composiciones de liberacion retardada de linaclotida. | |
| PH12014501991B1 (en) | Phenicol antibacterials | |
| PH12015500724A1 (en) | 1, 2, 4-triazine derivatives for the treatment of viral infections | |
| PH12016501724A1 (en) | Isoindolinone compounds as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | |
| PH12016501619A1 (en) | Substituted fused heterocycles as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | |
| WO2015059463A3 (en) | Treatment of beta-catenin related diseases8 | |
| IN2012DN02793A (enExample) | ||
| MX366499B (es) | Composicion farmaceutica liquida. | |
| HK1257296A1 (zh) | 新的化合物及其用途 | |
| IN2014MU00916A (enExample) | ||
| MX2015014958A (es) | Nuevos derivados de triazolona o sales de la misma y composicion farmaceutica que comprende a la misma. | |
| WO2016140910A3 (en) | Compositions and methods of using anti-mullerian hormone for treatment of infertility | |
| WO2015111004A3 (en) | Improved process for the preparation of chlorophenyl trifluoroethanone | |
| IN2013MU02055A (enExample) | ||
| WO2016020408A3 (en) | Compounds for preventing ototoxicity | |
| WO2014128728A3 (en) | Solid forms of cabazitaxel and processes for preparation thereof | |
| WO2015044434A3 (de) | FLUOR-9-METHYL-ß-CARBOLINE | |
| WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
| MX360040B (es) | Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno. | |
| MX2020011170A (es) | Derivados de 1-imidazotiadiazol-2h-pirrol-5-ona. | |
| HK40032669A (en) | Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate |